| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0168-8278(95)80108-1 |
| P698 | PubMed publication ID | 7545199 |
| P2093 | author name string | Naccarato R | |
| De Maria N | |||
| Cecchetto A | |||
| Floreani A | |||
| Farinati F | |||
| Marafin C | |||
| Burra P | |||
| Cardin R | |||
| Della Libera G | |||
| Lecis E | |||
| P433 | issue | 4 | |
| P921 | main subject | glutathione | Q116907 |
| P304 | page(s) | 449-456 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis | |
| P478 | volume | 22 |
| Q40279228 | 17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures |
| Q38336861 | A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice |
| Q42987619 | A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals |
| Q34278390 | A metabonomic study of cardioprotection of ginsenosides, schizandrin, and ophiopogonin D against acute myocardial infarction in rats |
| Q42987473 | A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C. |
| Q73898048 | Adult beta-thalassemic patients with chronic hepatitis C: long-term efficacy of alpha-IFN treatment |
| Q33738759 | Alcohol intake and porphyria cutanea tarda |
| Q22305502 | Alcoholic liver disease and hepatitis C: a frequently underestimated combination |
| Q34464913 | Alpha-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to interferon therapy? |
| Q24805238 | Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis |
| Q57661008 | Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C |
| Q27487944 | Arsenic Trioxide Inhibits Hepatitis C Virus RNA Replication through Modulation of the Glutathione Redox System and Oxidative Stress |
| Q49232850 | Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease |
| Q35538324 | Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice |
| Q50560311 | Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy. |
| Q87355706 | Clinical relevance of antibodies to cardiolipin in patients with chronic hepatitis C |
| Q47876306 | Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection |
| Q34279897 | Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami |
| Q41917521 | Comparison of the prophylactic effect of silymarin and deferoxamine on iron overload-induced hepatotoxicity in rat. |
| Q38466831 | Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful? |
| Q39375039 | Cu/Zn superoxide dismutase (SOD1) induction is implicated in the antioxidative and antiviral activity of acetylsalicylic acid in HCV-expressing cells. |
| Q71605631 | Cysteine and glutathione in the liver of patients with primary biliary cirrhosis |
| Q43031977 | DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study |
| Q39021863 | Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice infected with Schistosoma mansoni |
| Q33788123 | Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease |
| Q37700560 | Effect of hydrogen-rich water on oxidative stress, liver function, and viral load in patients with chronic hepatitis B |
| Q42990965 | Effect of liver steatosis on therapeutic response in chronic hepatitis C virus genotype 1 infected patients in hungary |
| Q73044020 | Effects of hepatocellular iron imbalance on nitric oxide and reactive oxygen intermediates production in a model of sepsis |
| Q42993714 | Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees |
| Q42170063 | Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial |
| Q43040192 | Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease |
| Q46547118 | Elevated serum ALT levels during pegylated interferon monotherapy may be caused by hepatic iron overload |
| Q73409676 | Elevated serum ferritin level in acute myocardial infarction |
| Q36146443 | Epoetin alfa for the treatment of combination therapy-induced hemolytic anemia in patients infected with hepatitis C virus |
| Q43439508 | Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection |
| Q34772506 | Estrogens receptors and oxidative damage in the liver |
| Q35724668 | Evaluation of the effects of oral N-acetylcysteine and a placebo in paraclinical and oxidative stress parameters of patients with chronic hepatitis B. |
| Q41654021 | Exacerbation of insulin resistance and hepatic steatosis deriving from zinc deficiency in patients with HCV-related chronic liver disease |
| Q44716307 | Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma |
| Q46920591 | Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis |
| Q44224826 | Expression of uncoupling protein-2 in biliary epithelial cells in primary biliary cirrhosis |
| Q44849724 | Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients |
| Q33743274 | Fat content, fatty acid pattern and iron content in livers of turkeys with hepatic lipidosis. |
| Q37240288 | Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells |
| Q90151313 | Flaviviridae Viruses and Oxidative Stress: Implications for Viral Pathogenesis |
| Q90376281 | Fluorescence spectroscopy as an efficient tool for staging the degree of liver fibrosis: an in vivo comparison with MRI |
| Q37483740 | Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. |
| Q38927842 | Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity |
| Q36089906 | Glycoside rich fraction from Spondias pinnata bark ameliorate iron overload induced oxidative stress and hepatic damage in Swiss albino mice |
| Q43821840 | HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis |
| Q35990088 | Heme oxygenase-1 mRNA expression in egyptian patients with chronic liver disease |
| Q42980668 | Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype. |
| Q37614074 | Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia |
| Q35154024 | Hepatic HMOX1 expression positively correlates with Bach-1 and miR-122 in patients with HCV mono and HIV/HCV coinfection |
| Q46967704 | Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. |
| Q43037813 | Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major |
| Q43241172 | Hepatic lipid peroxidation and antioxidant micronutrients in hepatitis virus C liver recipients with and without disease recurrence. |
| Q42263051 | Hepatic oxidative stress in ovariectomized transgenic mice expressing the hepatitis C virus polyprotein is augmented through suppression of adenosine monophosphate-activated protein kinase/proliferator-activated receptor gamma co-activator 1 alpha s |
| Q46789982 | Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin |
| Q27490473 | Hepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor -Dependent Manner: a New Contributor to HCV-Induced Oxidative Stress |
| Q33717232 | Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication |
| Q92607293 | Hepatitis C virus core or NS3/4A protein expression preconditions hepatocytes against oxidative stress and endoplasmic reticulum stress |
| Q24304356 | Hepatitis C virus core protein suppresses mitophagy by interacting with parkin in the context of mitochondrial depolarization |
| Q45749242 | Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up |
| Q35800315 | Hepatitis C virus to hepatocellular carcinoma. |
| Q36993948 | Hepatitis C virus-induced mitochondrial dysfunctions |
| Q43047092 | Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species |
| Q42999424 | Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. |
| Q33779089 | Hepcidin and the iron enigma in HCV infection |
| Q47993571 | Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. |
| Q77485792 | Histopathology of the liver in children with chronic hepatitis C viral infection |
| Q77169958 | Host- and disease-specific factors affecting steatosis in chronic hepatitis C |
| Q73628545 | Hyaluronate levels and markers of oxidative stress in the serum of Sudanese subjects at risk of infection with Schistosoma mansoni |
| Q31824216 | Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease |
| Q35086429 | Impact of oestrogens on the progression of liver disease |
| Q44104438 | Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients |
| Q37208055 | In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features |
| Q46592985 | In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis |
| Q83259329 | In vitro-targeted gene identification in patients with hepatitis C using a genome-wide microarray technology |
| Q58780577 | Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C |
| Q37734105 | Increased frequency of micronuclei in the lymphocytes of patients chronically infected with hepatitis B or hepatitis C virus |
| Q51910766 | Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. |
| Q44535186 | Insulin resistance/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection |
| Q33834811 | Integrated cytokine and metabolic analysis of pathological responses to parasite exposure in rodents |
| Q37654443 | Interaction between hepatitis C virus and metabolic factors |
| Q35821487 | Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus |
| Q42995489 | Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial |
| Q33590854 | Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin |
| Q74063636 | Iron and the response to treatment of hepatitis C |
| Q42979311 | Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus. |
| Q38548605 | Iron metabolic disorder in chronic hepatitis C: insights from recent evidence |
| Q38164077 | Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis |
| Q36177903 | Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance |
| Q42990376 | Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study |
| Q73520267 | Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial |
| Q79264030 | Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C |
| Q36712554 | Iron, HCV and the liver |
| Q45411351 | Lipid peroxidation and antioxidative status in beta-thalassemia major patients with or without hepatitis C virus infection |
| Q42988688 | Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. |
| Q27477844 | Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study |
| Q26773294 | Liver pathology of hepatitis C, beyond grading and staging of the disease |
| Q55438778 | Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker. |
| Q42207865 | Mangosteen xanthones suppress hepatitis C virus genome replication |
| Q35838651 | Manipulation of iron to determine survival: competition between host and pathogen |
| Q50320474 | Mitochondrial Proteins Coded by Human Tumor Viruses |
| Q38151252 | Mitochondrial reactive oxygen species as a mystery voice in hepatitis C. |
| Q79832130 | Molecular mechanism of iron metabolism and overload in chronic hepatitis C |
| Q38504324 | Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions. |
| Q50554150 | Neutrophil function and apoptosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin. |
| Q44105272 | Non-transferrin-bound iron in untreated and ribavirin-treated chronic hepatitis C patients |
| Q33498313 | Nonhepatic manifestations and combined diseases in HCV infection |
| Q44360006 | Oxidant stress is a significant feature of primary biliary cirrhosis. |
| Q35349621 | Oxidative DNA damage accumulation in gastric carcinogenesis |
| Q28368984 | Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection |
| Q50580767 | Oxidative status in chronic hepatitis C: the influence of antiviral therapy and prognostic value of serum hydroperoxide assay. |
| Q83340455 | Oxidative stress and apoptosis in hepatitis C: the core issue |
| Q33904328 | Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma |
| Q38127242 | Oxidative stress and hepatitis C virus |
| Q33250267 | Oxidative stress in hepatitis C infected end-stage renal disease subjects |
| Q34025940 | Pathogenesis of liver fibrosis: role of oxidative stress |
| Q40700090 | Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels |
| Q33687277 | Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients. |
| Q79176935 | Pilot Study of the Relationship Between Histologic Progression and Hepatic Iron Concentration in Chronic Hepatitis C |
| Q45405926 | Possible correlation between iron deposition and enhanced proliferating activity in hepatitis C virus-positive hepatocellular carcinoma in Myanmar (Burma). |
| Q26853520 | Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy |
| Q51758507 | Protection of estrogens against the progression of chronic liver disease. |
| Q40593951 | Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells |
| Q44101580 | Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients |
| Q44571797 | Relationship between iron stores and diabetes mellitus in patients infected by hepatitis C virus: a case-control study |
| Q44734126 | Relationship between levels of DNA damage in lymphocytes and histopathological severity of chronic hepatitis C and various clinical forms of hepatitis B. |
| Q36680651 | Relationship of Oxidative Stress with HIV Disease Progression in HIV/HCV Co-infected and HIV Mono-infected Adults in Miami. |
| Q41904355 | Retracted: Role of Hepatitis C Virus Induced Osteopontin in Epithelial to Mesenchymal Transition, Migration and Invasion of Hepatocytes |
| Q42988450 | Role of alcohol in the progression of liver disease caused by hepatitis C virus infection |
| Q45253874 | Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C. |
| Q41983643 | Role of free radicals in liver diseases. |
| Q36086225 | Role of phenolics from Spondias pinnata bark in amelioration of iron overload induced hepatic damage in Swiss albino mice |
| Q32028377 | Serum amino-terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following alpha-interferon therapy |
| Q42993889 | Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype |
| Q56974269 | Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells |
| Q46500969 | Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis. |
| Q90467572 | Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation |
| Q43758750 | Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases |
| Q39016620 | Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload |
| Q42994808 | Steatosis and intrahepatic hepatitis C virus in chronic hepatitis |
| Q80353465 | Steatosis in chronic hepatitis C: fuel for overproduction of oxidative stress? |
| Q42988535 | Superoxide dismutase in patients with chronic hepatitis C virus infection |
| Q46712698 | Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis |
| Q34263814 | The contribution of endogenous sources of DNA damage to the multiple mutations in cancer |
| Q35866167 | The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection |
| Q34408947 | The management of chronic hepatitis C virus infection |
| Q33952683 | The management of porphyria cutanea tarda |
| Q77738395 | The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C |
| Q42001692 | The role of liver biopsy in detection of hepatic oxidative stress. |
| Q47972672 | The role of serum ferritin in the diagnosis of iron deficiency anaemia in patients with liver cirrhosis |
| Q44215999 | The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B. |
| Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
| Q74090156 | Trace elements and chronic liver diseases |
| Q50485164 | Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C. |
| Q36880090 | Vitamin E in chronic liver diseases and liver fibrosis. |
| Q50573993 | Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. |
| Q41877536 | Why whey? Camel whey protein as a new dietary approach to the management of free radicals and for the treatment of different health disorders |
| Q35598407 | Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. |
| Q44486447 | Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease |
| Q73650883 | [Hyperinsulinemia in cirrhotic patients infected with hepatitis C virus] |
| Q38893853 | p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer |
Search more.